Company Profile
Opko Stock Price, News & Analysis
Company overview
Business overview
OPKO is a biopharmaceutical company focused on advancing a pipeline of therapeutic programs. Investors usually track how clinical data, regulatory milestones, and launch execution change the story over time.
Geographic Base and Sector Classification
Headquartered in the United States and listed on NASDAQ, OPKO is followed within the biotech universe for its exposure to catalyst-driven execution.
Business Model Characteristics
OPKO follows a catalyst-driven model where the market watches how the company turns development work into repeatable value creation.
Position Within the Biotechnology Landscape
Compared with more mature healthcare peers, OPKO sits closer to the development side of the biotechnology landscape, where timing around data and approvals matters most.
Why the stock is moving
OPKO is trading with a steady catalyst profile while investors wait for the next headline that changes the story.
Future catalysts
OPKO's near-term narrative is still split between diagnostics and the clinical pipeline, but the update feels more specific than usual. MDX2301 and the completed Epstein-Barr vaccine trial are the two pieces that can make the next stretch feel tangible, especially if they keep advancing without needing a reset in direction.
Recent news
The five most recent feed items are shown below in reverse chronological order.
- 01
- 02
- 03
- 04
- 05
Similar stocks
Peer names with similar commercial maturity, therapeutic overlap, or catalyst patterns.